Related Experiment Video

Updated: Jun 22, 2026

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction
08:00

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction

Published on: April 10, 2026

Therapeutic potential of dithiolethiones for hepatic diseases

Samuel Carroll Brooks1, Janie Sue Brooks, Woo Hyung Lee

  • 1Innovative Drug Research Center for Metabolic and Inflammatory Disease, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, South, Korea.

Pharmacology & Therapeutics
|July 1, 2009
PubMed

Insights

Oltipraz and similar dithiolethiones show promise for treating liver diseases by modulating the AMP-activated protein kinase (AMPK) pathway. These compounds offer novel therapeutic strategies for hepatic steatosis, inflammation, and disrupted energy metabolism.

Area of Science:

  • Pharmacology and Toxicology
  • Hepatology
  • Molecular Biology

Background:

  • Dithiolethiones, including oltipraz, are known for cancer chemoprevention.
  • Recent findings link dithiolethiones to the prevention/treatment of fibrosis, insulin resistance, and liver mitochondrial protection via AMP-activated protein kinase (AMPK) and S6K1.
  • The AMPK-S6K1 pathway influences Liver X receptor (LXR) activity and lipogenesis, identifying it as a target for hepatic steatosis.

Purpose of the Study:

  • To review the interaction between oltipraz and the AMPK-mTOR-S6K1 pathway.
  • To explore the role of this pathway in hepatocyte protection.
  • To highlight the therapeutic potential of dithiolethiones for hepatic diseases.

Main Methods:

  • Literature review focusing on oltipraz and the AMPK-mTOR-S6K1 pathway.
  • Analysis of studies investigating dithiolethione mechanisms in liver disease models.
  • Synthesis of findings on gene regulation related to hepatocyte protection.

Main Results:

  • Oltipraz and dithiolethiones interact with the AMPK-mTOR-S6K1 pathway.
  • This interaction regulates genes involved in protecting hepatocytes from intoxication, metabolic disruption, and inflammation.
  • Dithiolethiones demonstrate unique mechanisms for potential pharmaceutical intervention.

Conclusions:

  • Dithiolethiones, particularly oltipraz, offer a novel therapeutic approach for liver diseases.
  • Targeting the AMPK-mTOR-S6K1 pathway presents new possibilities for treating hepatic steatosis, inflammation, and metabolic dysfunction.
  • These compounds show significant potential for pharmaceutical intervention in hepatology.

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Preparation and Reactions of Thiols02:33

Preparation and Reactions of Thiols

Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...